Modulation of strain-specific differences in gene expression by cannabinoid type 2 receptor deficiency

Antonia Sophocleous1, Andrew H Sims, Aymen I Idris

  • 1Rheumatology and Bone Research Group, Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.

Insights

Cannabinoid receptor type 2 (Cnr2) deficiency impacts skeletal health differently across mouse strains. Gene expression analysis reveals Cnr2 affects numerous genes involved in immune response and cellular functions, explaining varied skeletal phenotypes.

Area of Science:

  • Genetics
  • Molecular Biology
  • Skeletal Biology

Background:

  • Cannabinoid receptor type 2 (Cnr2) plays a role in skeletal homeostasis.
  • Previous research indicates strain-dependent skeletal consequences of Cnr2 deficiency in mice.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying strain-specific skeletal phenotypes in Cnr2-deficient mice.
  • To compare global gene expression in bone from different mouse strains lacking Cnr2.

Main Methods:

  • Global gene expression analysis using microarrays in wild-type and Cnr2 (-/-) CD1 and C57BL/6 mice.
  • Bioinformatic analysis of gene expression data to identify differentially expressed genes and enriched gene ontology (GO) terms.

Main Results:

  • Trabecular bone volume showed opposing changes in Cnr2 (-/-) CD1 (increased) versus C57BL/6 (decreased) mice.
  • Microarray analysis identified 354 genes significantly affected by Cnr2 deficiency.
  • Bioinformatic analysis revealed Cnr2-dependent enrichment of GO terms related to immune response, nucleotide binding, extracellular region, and cell surface interactions.

Conclusions:

  • Cnr2 deficiency profoundly alters gene expression in mouse bone, affecting pathways like immune response and extracellular matrix organization.
  • These gene expression changes provide a molecular basis for the observed strain-specific skeletal phenotypes in Cnr2-deficient mice.
  • Understanding these genetic differences is crucial for deciphering the role of cannabinoid receptor signalling in skeletal health and disease.

Related Concept Videos

Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.4K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

3.1K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
20.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
14.6K